S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

NextPlat to Acquire Rural Florida Pharmacy for $1.5 Million

NextPlat Corp is expanding its PharmcoRx retail footprint into Northwest Florida, announcing a deal to acquire an independent pharmacy near Pensacola. The $1.5 million cash transaction aims to capture an underserved rural market while adding approximately $5.6 million in profitable annual revenue to the company's ledger.

NextPlat to Acquire Rural Florida Pharmacy for $1.5 Million
Photo: Bio & News

The acquisition, slated to close in the fourth quarter of 2026, secures a facility that has operated in the region for over 25 years. During the fiscal year ending December 31, 2025, the pharmacy reported $5.6 million in sales with 19% retail margins, operating with a debt-free balance sheet. NextPlat intends to modernize the location by introducing same-day delivery and online fulfillment services.

Beyond retail, the company plans to leverage this new location to market contracted services to institutional providers, including those participating in the federal 340B Drug Pricing Program and local long-term care facilities. This move aligns with NextPlat’s broader strategy to scale its healthcare division, which accounted for $39.7 million of its $54.3 million in total revenue last year. CEO David Phipps noted that the company views these rural acquisitions as a platform to differentiate the pharmacy experience while deploying higher-margin clinical services across the Florida panhandle.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!